From 2013 to 2023, the production of chemical and pharmaceutical products in Canada showed steady growth despite some volatility. The market experienced notable contractions in 2019 and 2020, with significant recovery in 2021. By 2023, production stood at 64.66 billion Canadian dollars, indicating overall resilience in the face of market disruptions. Year-on-year increases were generally modest, with the compound annual growth rate (CAGR) for the past five years averaging 0.71%.

Looking to the future, from 2024 onward, the market is expected to grow steadily, with a projected CAGR of 0.95% over the next five years. By 2028, the production value is forecasted to reach 69.16 billion Canadian dollars, representing a cumulative growth rate of 4.83% from 2023.

Future trends to watch for include:

Impact of technological advancements in chemical and pharmaceutical manufacturing.
Regulatory changes and their implications on production costs and capacity.
Emerging markets and global trade dynamics affecting export and import balances.